Patents Assigned to Regeneration Technology
-
Patent number: 12196490Abstract: A rotary kiln with a stirring function is provided, including a kiln head, a roller and a kiln tail. The roller is obliquely arranged on the kiln head and the kiln tail. The rotary kiln further includes a mounting shaft and stirring mechanisms. Linkage elements are arranged on an inner wall of the roller. The linkage elements are configured to drive the stirring mechanisms to perform a stirring operation. Each of the stirring mechanisms includes a rotating ring sleeve and two limiting slide bases. The rotating ring sleeve is provided with three telescopic frame bodies. A telescopic baffle is arranged in each of the three telescopic frame bodies. A secondary propulsion assembly is arranged in a mounting groove. A sealing cover is arranged at an inner end of the telescopic baffle. The telescopic frame body is communicated with the rotating ring sleeve.Type: GrantFiled: August 1, 2022Date of Patent: January 14, 2025Assignees: CHANGZHOU INSTITUTE OF TECHNOLOGY, Gaoyou Huanchuang Resources Regeneration Technology Co., Ltd.Inventors: Pin Zhou, Yu Zhao, Jie Li, Changjin Zhu, Haiming Yang
-
Patent number: 11903894Abstract: The method of treating a patient addicted to pain medication or opioids has the step administering acoustic shock waves or pressure pulses to the patient. A second embodiment includes a treatment to reduce a patient's pain caused by a medical condition and/or medical procedure to reduce or eliminate the taking of addictive pain medication. The treatment has the step of administering acoustic shock waves or pressure pulses directed to an area near a source of the pain or to one or more reflexology zones or to one or more reflexology zones and to an area near the source of the pain or both to treat the medical condition or prior to the medical procedure or during the medical procedure or after the medical procedure or any combination thereof.Type: GrantFiled: May 24, 2022Date of Patent: February 20, 2024Assignee: Softwave Tissue Regeneration Technologies, LLCInventors: John F. Warlick, John Patrick Finney
-
Patent number: 11844739Abstract: A handheld acoustic shock wave or pressure pulse applicator device has a body structure and an applicator head. The body structure has a proximal end and a distal end with a longitudinal axis extending between the ends. The applicator head is at the distal end. the head emits pressure pulses or shock waves at an inclined angle relative to the longitudinal axis of the body structure. The applicator head has a balloon or lens or membrane through which the emitted pressure pulses or shock waves pass. The lens or membrane is configured to be coupled directly or indirectly to an exposed soft tissue surface of a palate inside a patient's mouth to direct emitted pressure pulses or shock waves to the brain. The applicator device can be configured with the inclined obtuse angle fixed between 150 degrees and 90 degrees or can be adjustable between 180 degrees and 90 degrees.Type: GrantFiled: November 23, 2021Date of Patent: December 19, 2023Assignee: Softwave Tissue Regeneration Technologies, LLCInventor: John F. Warlick
-
Patent number: 11839394Abstract: The present invention relates to a reflector for an acoustic shock or pressure wave head, wherein the reflector comprises an acoustically reflective surface formed by a body of rotation, said body of rotation being formed by rotation of an elliptical segment about a rotation axis which extends through a focal point of the ellipse and encloses an angle ? between 0.1° and 30° with the main axis of the ellipse.Type: GrantFiled: June 25, 2021Date of Patent: December 12, 2023Assignees: Medizinische Universität Innsbruck, Heart Regeneration Technologies GMBHInventors: Christian Dorfmüller, Johannes Holfeld, Michael Grimm
-
Patent number: 11826301Abstract: A method of modulating glandular secretions by administering acoustic shock waves to a gland, includes the steps of activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves and subjecting the gland to acoustic shock waves stimulating the gland to have a modulated response. The modulated response is one of an adjustment in hormonal release which increases low level output, decreases high level output or stabilizes erratic output. The emitted acoustic shock waves are focused or unfocused low energy acoustic shock waves. The gland underlies the patient's skin. The shock wave generator is acoustically coupled to the patient's skin using a coupling gel or liquid. The gland is one of a testicle, ovary, pituitary gland, adrenal gland, thyroid gland, thymus, pineal gland, parathyroid, or hypothalamus. The method can be repeated one or more times.Type: GrantFiled: May 23, 2022Date of Patent: November 28, 2023Assignee: Softwave Tissue Regeneration Technologies, LLCInventor: John F. Warlick
-
Patent number: 11771620Abstract: The method of treating a patient addicted to pain medication or opioids has the step administering acoustic shock waves or pressure pulses to the patient. A second embodiment includes a treatment to reduce a patient's pain caused by a medical condition and/or medical procedure to reduce or eliminate the taking of addictive pain medication. The treatment has the step of administering acoustic shock waves or pressure pulses directed to an area near a source of the pain or to one or more reflexology zones or to one or more reflexology zones and to an area near the source of the pain or both to treat the medical condition or prior to the medical procedure or during the medical procedure or after the medical procedure or any combination thereof.Type: GrantFiled: May 24, 2022Date of Patent: October 3, 2023Assignee: Softwave Tissue Regeneration Technologies, LLCInventors: John F. Warlick, John Patrick Finney
-
Patent number: 11771621Abstract: The method of treating a patient addicted to pain medication or opioids has the step administering acoustic shock waves or pressure pulses to the patient. A second embodiment includes a treatment to reduce a patient's pain caused by a medical condition and/or medical procedure to reduce or eliminate the taking of addictive pain medication. The treatment has the step of administering acoustic shock waves or pressure pulses directed to an area near a source of the pain or to one or more reflexology zones or to one or more reflexology zones and to an area near the source of the pain or both to treat the medical condition or prior to the medical procedure or during the medical procedure or after the medical procedure or any combination thereof.Type: GrantFiled: May 24, 2022Date of Patent: October 3, 2023Assignee: Softwave Tissue Regeneration Technologies, LLCInventors: John F. Warlick, John Patrick Finney
-
Publication number: 20230029864Abstract: A rotary kiln with a stirring function is provided, including a kiln head, a roller and a kiln tail. The roller is obliquely arranged on the kiln head and the kiln tail. The rotary kiln further includes a mounting shaft and stirring mechanisms. Linkage elements are arranged on an inner wall of the roller. The linkage elements are configured to drive the stirring mechanisms to perform a stirring operation. Each of the stirring mechanisms includes a rotating ring sleeve and two limiting slide bases. The rotating ring sleeve is provided with three telescopic frame bodies. A telescopic baffle is arranged in each of the three telescopic frame bodies. A secondary propulsion assembly is arranged in a mounting groove. A sealing cover is arranged at an inner end of the telescopic baffle. The telescopic frame body is communicated with the rotating ring sleeve.Type: ApplicationFiled: August 1, 2022Publication date: February 2, 2023Applicants: CHANGZHOU INSTITUTE OF TECHNOLOGY, Gaoyou Huanchuang Resources Regeneration Technology Co., Ltd.Inventors: Pin Zhou, Yu Zhao, Jie Li, Changjin Zhu, Haiming Yang
-
Patent number: 11458069Abstract: A treatment method to reduce or eliminate a patient's symptoms caused by a medical condition or disease is disclosed. The treatment has the step of administering acoustic shock waves directed to one or more reflexology zones or to one or more reflexology zones and an area near a source of the pain if any is exhibited to treat the medical condition. The treatment further has the steps of activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves and subjecting the one or more reflexology zones or the one or more reflexology zones and the area near a source of the medical condition or pain, if any is exhibited, to acoustic shock waves to treat the medical condition.Type: GrantFiled: March 14, 2019Date of Patent: October 4, 2022Assignee: Softwave Tissue Regeneration Technologies, LLCInventors: John F. Warlick, John Patrick Finney
-
Patent number: 11389372Abstract: A method of modulating glandular secretions by administering acoustic shock waves to a reflexology zone has been discovered. In one preferred embodiment, a treatment method achieves one or more of a) modulating blood sugar levels, b) stimulating insulin production levels or c) normalizing A1C levels by administering acoustic shock waves to a reflexology zone or region of a patient. The treatment method further has the steps of: activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves; subjecting the reflexology zone to acoustic shock waves stimulating the pancreas to have a modulated response wherein the modulated response is one of an adjustment in blood sugar levels or insulin production and release or normalizing A1C levels which increases low level output, decreases high level output or stabilizes erratic output; and wherein the emitted acoustic shock waves are focused or unfocused.Type: GrantFiled: June 15, 2018Date of Patent: July 19, 2022Assignee: Softwave Tissue Regeneration Technologies, LLCInventors: John F. Warlick, John Patrick Finney, Janey Lynn Watts
-
Patent number: 11389370Abstract: A method of treating red blood cells of a human patient has the steps of activating an acoustic shock wave generator or source to emit acoustic shock waves and subjecting a vascular system containing red blood cells and surrounding muscle tissue peripherally through an extremity of a patient to the acoustic shock waves by stimulating the extremity wherein the extremity is positioned within a path of the emitted shock waves and away from a geometric focal volume or point of the emitted shock waves. The methods also treat muscle tissue of aging patients, from muscle regeneration or athletes for legal performance enhancement without drugs.Type: GrantFiled: April 18, 2016Date of Patent: July 19, 2022Assignee: Softwave Tissue Regeneration Technologies, LLCInventor: John Warlick
-
Patent number: 11389371Abstract: A method of modulating glandular secretions by administering acoustic shock waves to a gland, includes the steps of activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves and subjecting the gland to acoustic shock waves stimulating the gland to have a modulated response. The modulated response is one of an adjustment in hormonal release which increases low level output, decreases high level output or stabilizes erratic output. The emitted acoustic shock waves are focused or unfocused low energy acoustic shock waves. The gland underlies the patient's skin. The shock wave generator is acoustically coupled to the patient's skin using a coupling gel or liquid. The gland is one of a testicle, ovary, pituitary gland, adrenal gland, thyroid gland, thymus, pineal gland, parathyroid, or hypothalamus. The method can be repeated one or more times.Type: GrantFiled: May 21, 2018Date of Patent: July 19, 2022Assignee: Softwave Tissue Regeneration Technologies, LLCInventor: John F. Warlick
-
Patent number: 11389373Abstract: The method of treating a patient addicted to pain medication or opioids has the step administering acoustic shock waves or pressure pulses to the patient. A second embodiment includes a treatment to reduce a patient's pain caused by a medical condition and/or medical procedure to reduce or eliminate the taking of addictive pain medication. The treatment has the step of administering acoustic shock waves or pressure pulses directed to an area near a source of the pain or to one or more reflexology zones or to one or more reflexology zones and to an area near the source of the pain or both to treat the medical condition or prior to the medical procedure or during the medical procedure or after the medical procedure or any combination thereof.Type: GrantFiled: March 14, 2019Date of Patent: July 19, 2022Assignee: Softwave Tissue Regeneration Technologies, LLCInventors: John F. Warlick, John Patrick Finney
-
Patent number: 11311454Abstract: A handheld acoustic shock wave or pressure pulse applicator device has a body structure and an applicator head. The body structure has a proximal end and a distal end with a longitudinal axis extending between the ends. The applicator head is at the distal end. the head emits pressure pulses or shock waves at an inclined angle relative to the longitudinal axis of the body structure. The applicator head has a balloon or lens or membrane through which the emitted pressure pulses or shock waves pass. The lens or membrane is configured to be coupled directly or indirectly to an exposed soft tissue surface of a palate inside a patient's mouth to direct emitted pressure pulses or shock waves to the brain. The applicator device can be configured with the inclined obtuse angle fixed between 150 degrees and 90 degrees or can be adjustable between 180 degrees and 90 degrees.Type: GrantFiled: March 28, 2019Date of Patent: April 26, 2022Assignee: Softwave Tissue Regeneration Technologies, LLCInventor: John F. Warlick
-
Patent number: 11096706Abstract: The present invention relates to a reflector for an acoustic shock or pressure wave head, wherein the reflector comprises an acoustically reflective surface formed by a body of rotation, said body of rotation being formed by rotation of an elliptical segment about a rotation axis which extends through a focal point of the ellipse and encloses an angle ? between 0.1° and 30° with the main axis of the ellipse.Type: GrantFiled: October 21, 2015Date of Patent: August 24, 2021Assignees: Medizinische Universität Innsbruck, Heart Regeneration Technologies GMBHInventors: Christian Dorfmüller, Johannes Holfeld, Michael Grimm
-
Patent number: 9238044Abstract: The present invention relates to development of bioactive glass/glass-ceramic composition that are able to promote a fast deposition layer of carbonated hydroxyapatite upon immersion in simulated body fluid (SBF) for time periods as short as one hour. Such composition might include fluorides, and a variety of oxides (or their precursor compounds), such as Na2O—Ag2O—SrO—CaO—MgO—ZnO—P2O5—SiO2—Bi2O3—B2O3—CaF2, be prepared by the melt route or by the sol-gel process, with the specific composition and the preparation route selected according to the intended functionalities, which can present controlled biodegradation rate and bactericidal activity. The powders derived from glass melts purred in cold water (frits) may completely densify by sintering at temperatures up to 800° C. without devitrification, resulting in bioglass compacts with high flexural strength (˜85 MPa). The bioactive glass powders prepared by sol-gel densify at lower temperatures due to their higher specific surface area and reactivity.Type: GrantFiled: April 5, 2012Date of Patent: January 19, 2016Assignee: REG4LIFE REGENERATION TECHNOLOGY, S.A.Inventors: José Maria Da Fonte Ferreira, Ashutosh Goel
-
Publication number: 20140193499Abstract: The present invention relates to development of bioactive glass/glass-ceramic composition that are able to promote a fast deposition layer of carbonated hydroxyapatite upon immersion in simulated body fluid (SBF) for time periods as short as one hour. Such composition might include fluorides, and a variety of oxides (or their precursor compounds), such as Na2O—Ag2O—SrO—CaO—MgO—ZnO—P2O5—SiO2—Bi2O3—B2O3—CaF2, be prepared by the melt route or by the sol-gel process, with the specific composition and the preparation route selected according to the intended functionalities, which can present controlled biodegradation rate and bactericidal activity. The powders derived from glass melts purred in cold water (frits) may completely densify by sintering at temperatures up to 800° C. without devitrification, resulting in bioglass compacts with high flexural strength (˜85 MPa). The bioactive glass powders prepared by sol-gel densify at lower temperatures due to their higher specific surface area and reactivity.Type: ApplicationFiled: April 5, 2012Publication date: July 10, 2014Applicant: REG4LIFE REGENERATION TECHNOLOGY, S.A.Inventors: José Maria Da Fonte Ferreira, Ashutosh Goel
-
Patent number: 8652503Abstract: A bone paste useful in the orthopedic arts, for example in the repair of non-union fractures, periodontal ridge augmentation, craniofacial surgery, implant fixation, impaction grafting, or any other procedure in which generation of new bone is deemed necessary, is provided by a composition comprising a substantially bioabsorbable osteogenic compound in a gelatin matrix. In various embodiments, the osteogenic compound is selected from (i) demineralized bone matrix (DBM); (ii) bioactive glass ceramic, BIOGLASS®, bioactive ceramic, calcium phosphate ceramic, hydroxyapatite, hydroxyapatite carbonate, corraline hydroxyapatite, calcined bone, tricalcium phosphate, or like material; (iii) bone morphogenetic protein, TGF-?, PDGF, or mixtures thereof, natural or recombinant; and (iv) mixtures of (i)-(iii).Type: GrantFiled: June 14, 2005Date of Patent: February 18, 2014Assignees: University of Florida Research Foundation, Inc., Regeneration Technologies, Inc.Inventors: John F. Wironen, Jamie M. Grooms
-
Publication number: 20110091516Abstract: The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic gent to attract a desired cell.Type: ApplicationFiled: September 9, 2010Publication date: April 21, 2011Applicant: Regeneration Technologies, Inc.Inventors: C. Randal Mills, John R. Bianchi, Michael R. Roberts, David T. Cheung, Chandrasekaran Nataraj, John W. Howell, JR.
-
Patent number: 7775995Abstract: The invention relates to a device for the generation of shock waves for medical therapy, having a shock source, an energy storage and a switch, wherein the energy storage is a capacitor with a high capacity.Type: GrantFiled: January 30, 2007Date of Patent: August 17, 2010Assignee: Tissue Regeneration Technologies LLCInventor: Axel Voss